LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.65 | 21.74 | 1876 | 3754 | 0.4997 | 0.8218 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.65 | 21.74 | 1883 | 3754 | 0.5016 | 0.8227 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.65 | 21.74 | 1974 | 3754 | 0.5258 | 0.8343 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.62 | 21.74 | 1888 | 4150 | 0.4549 | 0.8025 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.62 | 21.74 | 1966 | 4150 | 0.4736 | 0.8122 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.62 | 21.74 | 2035 | 4150 | 0.4903 | 0.8204 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.62 | 21.74 | 2087 | 4150 | 0.5028 | 0.8265 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.59 | 21.74 | 1994 | 4492 | 0.4439 | 0.7996 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.59 | 21.74 | 2061 | 4492 | 0.4588 | 0.8073 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.59 | 21.74 | 2142 | 4492 | 0.4768 | 0.8164 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 47.59 | 21.74 | 2206 | 4492 | 0.4911 | 0.8234 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.56 | 21.74 | 2161 | 4838 | 0.4466 | 0.8036 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.56 | 21.74 | 2232 | 4838 | 0.4613 | 0.8111 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.56 | 21.74 | 2220 | 4838 | 0.4588 | 0.8098 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 49.56 | 21.74 | 2292 | 4838 | 0.4737 | 0.8173 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.53 | 21.74 | 2285 | 5150 | 0.4436 | 0.8042 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.53 | 21.74 | 2351 | 5150 | 0.4564 | 0.8107 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.53 | 21.74 | 2344 | 5150 | 0.4551 | 0.8100 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 51.53 | 21.74 | 2421 | 5150 | 0.4700 | 0.8175 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.50 | 21.74 | 2380 | 5425 | 0.4386 | 0.8034 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.50 | 21.74 | 2437 | 5425 | 0.4492 | 0.8088 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.50 | 21.74 | 2413 | 5425 | 0.4447 | 0.8065 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 53.50 | 21.74 | 2524 | 5425 | 0.4652 | 0.8167 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 21.74 | 2486 | 5768 | 0.4309 | 0.8015 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 55.48 | 21.74 | 2558 | 5768 | 0.4434 | 0.8079 | MN20160310_N01 | E05 |